Prot #I3Y-US-X015: NU 18B04: MONARCH-PRECISION PROGRAM: A Prospective, Randomized, Open Label, Phase II Study of Abemaciclib Combined with Fulvestrant vs. Abemaciclib in Patients with Molecularly Defined Subtypes of Hormone-Receptor Positive (HR+), HER-2